Prenatal Mindfulness & Hypertension Study
HTN
Prenatal Mindfulness Training for Pregnant Women at Risk for Hypertension
2 other identifiers
interventional
30
1 country
1
Brief Summary
Hypertensive disorders of pregnancy are one of the greatest causes of death to mothers and babies. These disorders affect 1 out of every 10 pregnancies, the rate is increasing in the United States, and rate of recurrence is as high as 50%. Treatments to prevent hypertensive disorders of pregnancy from happening in future pregnancies are limited. There are currently no effective interventions to prevent hypertension recurrence in pregnancy that do not involve medications. Mindfulness interventions hold great potential as a medication-free approach to prevent the recurrence of hypertension in pregnant women with histories of hypertensive disorders. However, traditional group-based mindfulness training interventions, requiring 2.5 hours of class attendance for 8 weeks plus a full-day retreat, are very difficult for pregnant women with medical conditions to attend. The goal of the current study is to determine if phone-delivered mindfulness training is an acceptable intervention among pregnant women with histories of hypertensive disorders of pregnancy. 20 pregnant women with histories of hypertensive disorders of pregnancy will be randomly picked to participate in an 8-week phone-delivered mindfulness training intervention (N=10) or usual care (N=10). All women will undergo blood pressure monitoring before and after the intervention. The investigators predict that phone-delivered mindfulness training will reduce risk for hypertension recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2018
CompletedFirst Posted
Study publicly available on registry
September 20, 2018
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedResults Posted
Study results publicly available
June 1, 2023
CompletedJune 1, 2023
May 1, 2023
2.8 years
August 28, 2018
April 20, 2023
May 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention and Adherence
Number of participants that completed greater than 5 mindfulness sessions or completed the follow up interview.
Through study completion, an average of 20 weeks
Secondary Outcomes (1)
Hypertension Diagnosis
Through study completion, an average of 20 weeks
Study Arms (2)
Mindfulness Training
EXPERIMENTALPhone-delivered mindfulness training
Treatment as Usual
NO INTERVENTIONPrenatal care
Interventions
Phone-delivered mindfulness training. 8 weeks of 30 minute phone sessions with an instructor, plus 15 minutes of self-guided practice.
Eligibility Criteria
You may qualify if:
- \> 18 years old,
- Singleton pregnancy,
- English speaking,
- \<20 weeks' gestation at enrollment,
- History of a hypertensive disorder in a prior pregnancy.
You may not qualify if:
- No current engagement in mindfulness training (defined as weekly yoga, mindfulness exercises (including on-line), or meditation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lifespanlead
- National Institute of General Medical Sciences (NIGMS)collaborator
Study Sites (1)
Women's Medicine Collaborative
Providence, Rhode Island, 20904, United States
Related Publications (4)
Bublitz MH, Anderson M, Bourjeily G, Salmoirago-Blotcher E. Psychological mechanisms of prenatal mindfulness training on antenatal blood pressure reduction: A pilot study. J Psychosom Res. 2025 Aug;195:112183. doi: 10.1016/j.jpsychores.2025.112183. Epub 2025 Jun 6.
PMID: 40505593DERIVEDSharp M, Ward LG, Pomerantz M, Bourjeily G, Guthrie KM, Salmoirago-Blotcher E, Desmarattes A, Bublitz MH. Prenatal Mindfulness Training and Interoceptive Awareness in Pregnant People at Risk for Hypertensive Disorders. J Integr Complement Med. 2024 Dec;30(12):1200-1208. doi: 10.1089/jicm.2024.0121. Epub 2024 Jul 8.
PMID: 38976481DERIVEDUnger KG, Sanapo L, Bourjeily G, Salmoirago-Blotcher E, Bublitz MH. The Impact of Mindfulness Treatment on Maternal Inflammation and Fetal Neurodevelopment Among Participants with Histories of Hypertensive Disorders. J Integr Complement Med. 2024 Jan;30(1):85-89. doi: 10.1089/jicm.2023.0254. Epub 2023 Sep 26.
PMID: 37751286DERIVEDBublitz MH, Salmoirago-Blotcher E, Sanapo L, Ayala N, Mehta N, Bourjeily G. Feasibility, acceptability, and preliminary effects of mindfulness training on antenatal blood pressure. J Psychosom Res. 2023 Feb;165:111146. doi: 10.1016/j.jpsychores.2023.111146. Epub 2023 Jan 5.
PMID: 36621212DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Margaret Bublitz
- Organization
- Lifespan Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret Bublitz, PhD
Women's Medicine Collaborative
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
August 28, 2018
First Posted
September 20, 2018
Study Start
April 1, 2019
Primary Completion
January 31, 2022
Study Completion
July 1, 2022
Last Updated
June 1, 2023
Results First Posted
June 1, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share